إعلان
إعلان
MGNX
MacroGenics, Inc.
1.63
USDبرعاية
+0.01
+0.93%
٠٢ يناير, ١٥:٤٠ UTC -5
مغلق
بعد الإغلاق
1.61
-0.01
-0.92%
تقارير أرباح MGNX
النسبة الإيجابية المفاجئة
MGNX تفوق 17 من 40 آخر التقديرات.
43%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$23.10M
/-$0.29
التغير الضمني من Q3 25 (Revenue/ EPS)
-68.29%
/-207.41%
التغير الضمني من Q4 24 (Revenue/ EPS)
+19.34%
/+16.00%
MacroGenics, Inc. earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, MGNX reported earnings of 0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.50 USD, resulting in a 153.84% surprise. Revenue reached 72.84 مليون, compared to an expected 14.99 مليون, with a 385.79% difference. The market reacted with a +8.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.29 USD, with revenue projected to reach 23.10 مليون USD, implying an decrease of -207.41% EPS, and decrease of -68.29% in Revenue from the last quarter.
الأسئلة الشائعة
What were MacroGenics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MacroGenics, Inc. reported EPS of $0.27, beating estimates by 153.84%, and revenue of $72.84M, 385.79% above expectations.
How did the market react to MacroGenics, Inc.'s Q3 2025 earnings?
The stock price moved up 8.84%, changed from $1.47 before the earnings release to $1.60 the day after.
When is MacroGenics, Inc. expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for MacroGenics, Inc.'s next earnings report?
Based on 9
analysts, MacroGenics, Inc. is expected to report EPS of -$0.29 and revenue of $23.10M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان